Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Deterioration of kidney renal function occurs in a minority of people due to contrast-required procedures. The purpose of this study is to compare two different interventions to reduce the risk of kidney injury after contrast medium exposition.
We will perform a randomized clinical trial following a modification of a previously published protocol (Merten et al.JAMA 2004;291(19):2328-34). Patients will be randomly assigned to one of two groups of treatment. Group A will receive 1 cc/kg/hour of 0.9% saline infusion starting 12 hours before and continuing 12 hours after the procedure. Group B will receive 3 cc/kg of sodium bicarbonate solution for one hour prior to procedure, then drip rate will be decreased to 1 cc/kg/hour until 6 hours post procedure.
We will perform a randomized clinical trial following a modification of a previously published protocol (Merten et al.JAMA 2004;291(19):2328-34). Patients will be randomly assigned to one of two groups of treatment. Group A will receive 1 cc/kg/hour of 0.9% saline infusion starting 12 hours before and continuing 12 hours after the procedure. Group B will receive 3 cc/kg of sodium bicarbonate solution for one hour prior to procedure, then drip rate will be decreased to 1 cc/kg/hour until 6 hours post procedure.
Phase 2/3 study Study Type: Interventional Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study.
Subjects: Consecutive samples of all inpatients who meet the inclusion criteria
Primary outcomes: Development of contrast induced nephropathy, defined as an increase in serum creatinine of 25% or more within 48 h after administration of contrast.
Secondary outcomes: change in serum bicarbonate; change in serum potassium; change in serum creatinine.
Expected total enrollment: 212
Allocation Assignment: Patients who meet inclusion criteria and agree to participate in the study will be assigned by a random number table to saline or bicarbonate, using closed envelopes and stratifying according to history of diabetes and type of procedure (cardiac catheterism or others).
Condition: Contrast Induced Nephropathy
Intervention: 75 cc of sodium bicarbonate (8.4%) mixed in 425 cc of D5W
Gender: both Age: 18+ years of age Recruitment Status: participants are currently being recruited
Facility location:
Universidad de Antioquia, Internal Medicine Department; Hospital Universitario San Vicente de Paul. Medellin, Colombia.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bicarbinate 150 mEq/L | Drug | 75 cc of sodium bicarbonate (8.4%) mixed in 425 cc of D5W |
| Measure | Description | Time Frame |
|---|---|---|
| development of contrast induced nephropathy, defined as an increase in serum creatinine of 25% or more within 48 h after administration of contrast | 48 h |
| Measure | Description | Time Frame |
|---|---|---|
| change in serum bicarbonate; change in serum potassium; change in serum creatinine | 48 h |
Not provided
Inclusion Criteria:
18+ years of age
Inpatient at Hospital Universitario San Vicente de Paúl scheduled to undergo diagnostic CT scan using contrast or angiography and either
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wilmar A Maya Salazar, MD | Universidad de Antioquia | Principal Investigator |
| Julián M Aristizábal, MD | Universidad de Antioquia | Study Chair |
| Oscar M Santos, MD | Universidad de Antioquia | Study Chair |
| John F Nieto, MD | Universidad de Antioquia | Study Chair |
| Liliana Jaramillo, MD | Universidad de Antioquia | Study Chair |
| Jorge I García, MD | Universidad de Antioquia | Study Chair |
| Fabian A Jaimes, MD | Universidad de Antioquia | Study Director |
| Alvaro García, MD | Universidad de Antioquia | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Universitario San Vicente Paúl | Medellín | Antioquia | 57 | Colombia |
Not provided
| ID | Term |
|---|---|
| D058186 | Acute Kidney Injury |
| D007674 | Kidney Diseases |
| ID | Term |
|---|---|
| D051437 | Renal Insufficiency |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |